Concepedia

Albert Elion‐Mboussa

AE

Statistics

Publications

9

Citations

975

H-Index

9

Active since

2006

Affiliations

Eli Lilly (United States)(Current)

The University of Texas Southwestern Medical Center

St Joseph's Health Care

Hôpital Raymond-Poincaré

Northwestern University

Albert Elion‐Mboussa is an author at Eli Lilly (United States) specializing in pharmacotherapy, tadalafil therapy, and medicine.

Publications per year

2006–2012

9

Publications

9

Tadalafil Administered Once Daily for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Dose Finding Study

Claus G. Roehrborn, Kevin T. McVary, Albert Elion‐Mboussa et al. · The Journal of Urology · 2008 · 290 citations

, , +11

Evaluation of the Efficacy and Safety of Once-a-Day Dosing of Tadalafil 5mg and 10mg in the Treatment of Erectile Dysfunction: Results of a Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial

Hartmut Porst, François Giuliano, Sidney Glina et al. · European Urology · 2006 · 200 citations

, , +8

Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a 1‐year, open‐label extension study

Craig F. Donatucci, Gerald Brock, Evan R. Goldfischer et al. · British Journal of Urology · 2011 · 106 citations

, , +15

Effects of Once-Daily Tadalafil on Erectile Function in Men with Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia

Hartmut Porst, Kevin T. McVary, Francesco Montorsi et al. · European Urology · 2009 · 96 citations

, , +14

Changes in peak urinary flow and voiding efficiency in men with signs and symptoms of benign prostatic hyperplasia during once daily tadalafil treatment

Claus G. Roehrborn, Jed Kaminetsky, Stephen M. Auerbach et al. · British Journal of Urology · 2009 · 74 citations

, , +16

1–5 of 9